MK
Manish Kumar
About Manish Kumar
Data last updated:
Manish Kumar has 2 years in corporate governance. Holds Director role. Currently with 2 companies, including Knollox Health World Private Limited and Atrillia Pharmaceuticals Private Limited. Engaged in Healthcare, General Business. Contributes to corporate operations. The largest current company by reported revenue is Knollox Health World Private Limited at ₹0.01 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 27 Jan 2025 | 2017 | ₹0.01 Cr (FY 2025) | Active | |
| Director | 02 Jul 2024 | 2024 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Manish Kumar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Manish Kumar
Manish Kumar has 2 years in corporate governance. Holds Director role. Currently with 2 companies, including Knollox Health World Private Limited and Atrillia Pharmaceuticals Private Limited. Engaged in Healthcare, General Business. Contributes to corporate operations. The largest current company by reported revenue is Knollox Health World Private Limited at ₹0.01 Cr (FY 2025).
Manish Kumar is associated with 2 companies as Director, including Knollox Health World Private Limited (₹0.01 Cr), Atrillia Pharmaceuticals Private Limited.
Manish Kumar has expertise in Healthcare, General Business.
Manish Kumar has 2 years in corporate governance.
By reported revenue, the largest current company of Manish Kumar is Knollox Health World Private Limited, with revenue of ₹0.01 Cr (FY 2025).
Manish Kumar currently holds positions at 2 companies: Knollox Health World Private Limited (₹0.01 Cr), Atrillia Pharmaceuticals Private Limited.